New York Times reporters Gina Kolata and Rebecca Robbins highlight how university researchers at MIT and Harvard laid the groundwork for the development of a new treatment for pancreatic cancer that “could wind up being the most significant advance in cancer treatment in 15 years, since the arrival of immunotherapy.” They write: “In 1982, Robert Weinberg, a scientist at MIT, made one of the seminal discoveries about how RAS genes fuel some cancers.”
Boston Herald reporter Lindsay Kalter writes that Prof. Ed Boyden is working on a new effort to develop technologies that would allow doctors to explore tumors using virtual reality. Boyden explains that he and his colleagues hope to use virtual reality to explore “what a tumor’s weaknesses are, and what makes it thrive.”
Boston Globe reporter Priyanka Dayal McCluskey writes that researchers from the Broad Institute and IBM are joining forces to examine why many cancer patients become resistant to drugs. The researchers hope this new effort could “help doctors prescribe more effective combinations of drugs for cancer patients.”